What is Acurx Pharmaceuticals LLC?
, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.30M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.